---
figid: PMC7760298__biology-09-00434-g001
figlink: pmc/articles/PMC7760298/figure/biology-09-00434-f001/
number: F1
caption: Prostaglandin E2 (PGE2) biosynthesis. Arachidonic acid (AA) is a polyunsaturated
  fatty acid that constitutes the phospholipid domain of most cell membranes and is
  released from the cellular membranes by cytoplasmic phospholipases A2 (PLA2). Free
  AA can be metabolized to PGE2 through the cyclooxygenase (COX) pathway. In this
  pathway, the key step is the enzymatic conversion of AA to the intermediate prostaglandin
  G2 (PGG2), which is then reduced to the intermediate PGH2 by the peroxidase activity
  of COX. PGH2 is sequentially metabolized to PGE2 by specific PGE synthases (cytosolic
  PGE synthase (cPGES), microsomal PGE synthase-1 (mPGES1), and mPGES2). PGE2 exerts
  its effects through ligation with four G-protein-coupled receptors (GPCRs), EP1–EP4.
  Each E-type prostanoid (EP) receptor couples to distinct signaling pathways. This
  figure was created using Servier Medical Art templates, which are licensed under
  a Creative Commons Attribution 3.0 Unported License; https://smart.servier.com.
pmcid: PMC7760298
papertitle: 'Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity.'
reftext: Federica Finetti, et al. Biology (Basel). 2020 Dec;9(12):434.
pmc_ranked_result_index: '33221'
pathway_score: 0.8754393
filename: biology-09-00434-g001.jpg
figtitle: Prostaglandin E2 (PGE2) biosynthesis
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7760298__biology-09-00434-g001.html
  '@type': Dataset
  description: Prostaglandin E2 (PGE2) biosynthesis. Arachidonic acid (AA) is a polyunsaturated
    fatty acid that constitutes the phospholipid domain of most cell membranes and
    is released from the cellular membranes by cytoplasmic phospholipases A2 (PLA2).
    Free AA can be metabolized to PGE2 through the cyclooxygenase (COX) pathway. In
    this pathway, the key step is the enzymatic conversion of AA to the intermediate
    prostaglandin G2 (PGG2), which is then reduced to the intermediate PGH2 by the
    peroxidase activity of COX. PGH2 is sequentially metabolized to PGE2 by specific
    PGE synthases (cytosolic PGE synthase (cPGES), microsomal PGE synthase-1 (mPGES1),
    and mPGES2). PGE2 exerts its effects through ligation with four G-protein-coupled
    receptors (GPCRs), EP1–EP4. Each E-type prostanoid (EP) receptor couples to distinct
    signaling pathways. This figure was created using Servier Medical Art templates,
    which are licensed under a Creative Commons Attribution 3.0 Unported License;
    https://smart.servier.com.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLA2G1B
  - PLA2G2A
  - PLA2G5
  - PLA2G10
  - PLA2G2D
  - PLA2G2E
  - PLA2G3
  - PLA2G2F
  - PLA2G12A
  - PLA2G4D
  - PLA2G2C
  - PLA2G4A
  - PLA2G7
  - PLA2G6
  - PLA2G4C
  - PLA2G12B
  - PTGER1
  - PTGER3
  - PTGER4
  - PGG
  - 13,14-Dihydro-15- Keto-PGs
  - PGE
  - 15-PGDH
  - PGE2
genes:
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G1B
  entrez: '5319'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2A
  entrez: '5320'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G5
  entrez: '5322'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G10
  entrez: '8399'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2D
  entrez: '26279'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2E
  entrez: '30814'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G3
  entrez: '50487'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2F
  entrez: '64600'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12A
  entrez: '81579'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4D
  entrez: '283748'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2C
  entrez: '391013'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4A
  entrez: '5321'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G7
  entrez: '7941'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G6
  entrez: '8398'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4C
  entrez: '8605'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12B
  entrez: '84647'
- word: EP1
  symbol: EP1
  source: hgnc_alias_symbol
  hgnc_symbol: PTGER1
  entrez: '5731'
- word: ЕРЗ
  symbol: EP3
  source: hgnc_alias_symbol
  hgnc_symbol: PTGER3
  entrez: '5733'
- word: EP4
  symbol: EP4
  source: hgnc_alias_symbol
  hgnc_symbol: PTGER4
  entrez: '5734'
chemicals:
- word: PGG
  source: MESH
  identifier: D011462
- word: 13,14-Dihydro-15- Keto-PGs
  source: MESH
  identifier: C034832
- word: PGE
  source: MESH
  identifier: D011458
- word: 15-PGDH
  source: MESH
  identifier: C515378
- word: PGE2
  source: MESH
  identifier: D015232
diseases: []
figid_alias: PMC7760298__F1
redirect_from: /figures/PMC7760298__F1
figtype: Figure
---
